Business Description
Harm Reduction Group
ISIN : SE0006261038
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.2 | |||||
Equity-to-Asset | 0.25 | |||||
Debt-to-Equity | 0.45 | |||||
Debt-to-EBITDA | -3.67 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 1.1 | |||||
Beneish M-Score | -2.13 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 71.67 | |||||
9-Day RSI | 55.18 | |||||
14-Day RSI | 47.3 | |||||
6-1 Month Momentum % | -22.61 | |||||
12-1 Month Momentum % | -44.2 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.27 | |||||
Quick Ratio | 0.54 | |||||
Cash Ratio | 0.04 | |||||
Days Inventory | 223.64 | |||||
Days Sales Outstanding | 20.73 | |||||
Days Payable | 140.04 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -217 | |||||
Shareholder Yield % | 14.76 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 40.24 | |||||
Operating Margin % | -14.57 | |||||
Net Margin % | -16.3 | |||||
FCF Margin % | -2.3 | |||||
ROE % | -52.68 | |||||
ROA % | -17.72 | |||||
ROIC % | -22.02 | |||||
ROC (Joel Greenblatt) % | -275.88 | |||||
ROCE % | -29.04 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.21 | |||||
PB Ratio | 0.98 | |||||
EV-to-EBIT | -2.69 | |||||
EV-to-EBITDA | -13.47 | |||||
EV-to-Revenue | 0.36 | |||||
EV-to-FCF | -16.31 | |||||
Earnings Yield (Greenblatt) % | -37.19 | |||||
FCF Yield % | -8.34 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Harm Reduction Group Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 166.534 | ||
EPS (TTM) (kr) | -0.097 | ||
Beta | 0.82 | ||
Volatility % | 102.67 | ||
14-Day RSI | 47.3 | ||
14-Day ATR (kr) | 0.016703 | ||
20-Day SMA (kr) | 0.110855 | ||
12-1 Month Momentum % | -44.2 | ||
52-Week Range (kr) | 0.0868 - 0.307 | ||
Shares Outstanding (Mil) | 413.96 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Harm Reduction Group Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Harm Reduction Group Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Harm Reduction Group Frequently Asked Questions
What is Harm Reduction Group(XSAT:NOHARM)'s stock price today?
When is next earnings date of Harm Reduction Group(XSAT:NOHARM)?
Does Harm Reduction Group(XSAT:NOHARM) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |